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De-repression of myelin-regulating gene expression  
after status epilepticus in mice lacking the  
C/EBP homologous protein CHOP
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Mooney, Tobias Engel 
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Abstract: The C/EBP homologous protein CHOP is normally present at low levels in cells but increases rapidly after 
insults such as DNA damage or endoplasmatic reticulum stress where it contributes to cellular homeostasis and 
apoptosis. By forming heterodimers with other transcription factors, CHOP can either act as a dominant-negative 
regulator of gene expression or to induce the expression of target genes. Recent work demonstrated that seizure-
induced hippocampal damage is significantly worse in mice lacking CHOP and these animals go on to develop an 
aggravated epileptic phenotype. To identify novel CHOP-controlled target genes which potentially influence the epi-
leptic phenotype, we performed a bioinformatics analysis of tissue microarrays from chop-deficient mice after pro-
longed seizures. GO analysis revealed genes associated with biological membranes were prominent among those 
in the chop-deficient array dataset and we identified myelin-associated genes to be particularly de-repressed. These 
data suggest CHOP might act as an inhibitor of myelin-associated processes in the brain and could be targeted to 
influence axonal regeneration or reorganisation.
Keywords: CHOP, epilepsy, mRNA microarray, myelin basic protein, status epilepticus
Introduction
CHOP (C/EBP homologous protein), also known 
as GADD153 (growth arrest and DNA damage 
153) or DDIT3 (DNA damage-induced transcript 
3), belongs to the C/EBP and jun/fos family of 
transcription factors containing a conserved 
basic-leucine zipper domain at the C-terminus 
(BZIP) which is involved in dimerization and 
DNA binding [1]. In contrast to other members 
of the C/EBP family, CHOP does not form 
homodimers, but instead forms heterodimers 
sequestering transcription factor partners in 
the nucleus as well as in the cytoplasm to either 
block or increase transcription of target genes 
[1, 2]. First identified as being induced by 
growth arrest and DNA damage [3], CHOP 
expression has since been shown to be 
increased by various stress stimuli, including 
hypoxia and starvation but stress of the endo-
plasmatic reticulum (ER) has been described 
as the main CHOP activating pathway [4-6]. The 
ER is the site of synthesis and folding of secre-
tory proteins and perturbations of ER homeo-
stasis lead to ER-stress which is sensed by 
three upstream signalling proteins activating 
the ER-specific unfolded protein response (UPR) 
[5]. CHOP expression can be induced by all 
three arms of the UPR; namely IRE1 (inositol-
requiring protein 1), PERK (protein kinase 
(PRK)-like ER kinase) and ATF6 (activating tran-
scription factor-6) [5] with the PERK pathway 
being the most prominent CHOP inducer [5]. In 
addition to expressional changes, CHOP activity 
can also be increased by its phosphorylation 
through the mitogen-activated protein kinase 
p38 [7].
CHOP activation is involved in a wide array of 
different functions which range from cell prolif-
eration to cell differentiation [5, 8, 9], however 
the main focus and effort to identify CHOP-
regulated target genes has been put on pro-
cesses related to cell death such as DOCs 
(down-stream of CHOP) [10], Bcl-2 (B-cell lym-
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phoma) [10], TRB3 (tribbles-related protein3) 
[11], GADD34 [12] and the BH3-only family 
members Bim and Puma [13, 14]. 
CHOP has been implicated in a wide array of 
diseases of the CNS [5] including Alzheimer’s 
disease [15] and in acute insults to the brain 
such as ischemia [16] and more recently 
epilepsy [17]. Whereas most studies propose 
a neuroprotective contribution of CHOP 
inactivation/depletion to disease pathology [8], 
more recent studies suggest a protective role 
of CHOP under certain circumstances [17, 18]. 
For example, chop deletion reduced life span 
and increased cell death in a mouse model 
of Pelizaeus-Merzbacher disease [19] and 
provided neuroprotection during hypoxia [20]. 
CHOP also seems to play an important role 
during normal physiology, as chop-deficient 
mice showed increased hippocampal apopto-
sis and diminished memory function [21]. We 
recently reported that mice lacking chop 
showed increased seizure-induced cell death 
[17] which was apparently caused by CHOP-
targeting of the E3 ubiquitin ligase MDM2 
which in turn increased the levels of the 
proapoptotic transcription factor p53 resulting 
in altered p53 signalling [17]. A complete analy-
sis of our microarray data was not performed 
and it is possible that other processes may be 
changed. Here, we identified myelin-associated 
genes to be targeted by CHOP where CHOP 
seems to carry out a transcriptional repressing 
role after seizures. These results demonstrate 
the context specific role of CHOP during cellular 
stress and normal physiology and show the 
importance of identifying potential and 
new CHOP-regulated target genes to fully 
understand its functions during pathology and 
normal physiology.
Material and methods
Mouse seizure model
All animal experiments were performed in 
accordance with the principles of the European 
Communities Council Directive (86/609/EEC), 
and procedures were approved by the Research 
Ethics Committee of the Royal College 
of Surgeons in Ireland. Experiments were 
performed as previously reported [17], using 
adult C57BL/6 wild-type (Harlan, Oxon, UK) and 
chop-/- mice which were originally back-crossed 
to C57BL/6 background for at least five 
generations (Jackson Laboratory, Maine, USA; 
B6.129S-Ddit3tm1Dron/J; [22]). First, mice were 
anaesthetized using isoflurane and placed in a 
stereotaxic frame. Then, three partial craniec-
tomies were performed to affix cortical 
skull-mounted EEG electrodes (Plastics One, 
Bilaney Consultants Ltd, Kent, UK), and EEG 
was recorded using a Grass Comet digital EEG. 
A guide cannula was affixed for intra-amygdala 
targeting, and the skull assembly was fixed in 
place with dental cement. After baseline EEG, 
kainic acid (0.3 µg in 0.2 µl PBS) (Sigma-Aldrich, 
Dublin, Ireland) was microinjected into the 
basolateral amygdala. Non-seizure control 
mice received 0.2 µl of intra-amygdala vehicle. 
Mice received intraperitoneal lorazepam (6 
mg/kg) 40 minutes after KA injection.
To record from the hippocampus and cortex at 
the same time, mice were implanted with a 
bipolar electrode (Plastics One, Bilaney 
Consultants Ltd, Kent, UK), into the dorsal CA3 
subfield of the hippocampus (Coordinates from 
Bregma; AP = -2.25 mm, L = -0.9 mm, V = -1.94 
mm) [23]. Epilepsy monitoring was performed 
via implanted EEG telemetry units, as 
previously described [17]. EEG data were 
acquired with EEG transmitters (Model: F20-
EET, Data Systems International, St. Paul, MN, 
USA) configured to record 2-channel EEG that 
were skull-affixed over dorsal hippocampi/ 
temporal cortex as described before [17]. Mice 
were euthanized at various time points after 
status epilepticus (1, 4, 8, 24 h or 72 h, and 14 
days). Animals were given a pentobarbital 
overdose and perfused with ice-cold saline to 
remove intravascular blood components. 
Brains for molecular and biochemical work 
were microdissected to obtain whole 
hippocampus [17]. For histology, mice were 
either perfusion-fixed with paraformaldehyde 
(4%) or brains fresh-frozen in 2-methylbutane 
(at -30°C). 
Histopathology
Fresh-frozen brains were processed on a 
cryostat in the coronal plane and 12 µm sec-
tions were collected at the level of dorsal 
hippocampus. Irreversible neuronal injury was 
assessed using Fluoro-Jade B (FJB) staining as 
described before [17]. Briefly, sections were 
post-fixed, incubated in 0.006% potassium 
permanganate, rinsed and transferred to 
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0.001% FJB solution (Chemicon Europe Ltd., 
Chandlers Ford, UK). Sections were then rinsed, 
dried, cleared and mounted in DPX (Sigma-
Aldrich, Dublin, Ireland).
Figure 1. Increased hippocampal CHOP protein levels after status epilepticus and during epileptogenesis. (A) 
Representative EEG traces from simultaneous cortical surface electrode recording (cortex) and intra-hippocam-
pal recording (intrahippo) during status epilepticus. (B) Representative FJB staining 24 h after status epilepticus 
of the ipsilateral hippocampus showing cell death (arrows) mainly restricted to the CA3 hippocampal subfield. 
(C) Representative EEG traces of spontaneous seizure 14 days post KA injection recorded from cortical surface 
electrodes. (D) Representative photomicrographs showing distribution of Neuropeptide Y (NPY) in the hippocampus 
of control and epileptic mice 14 days post KA injection. Note, extensive staining of mossy fibers and neuronal exten-
sions (arrows) in epileptic mice. (E) Representative western blots (n = 1 per lane) showing increased hippocampal 
ER-stress marker KDEL (BiP) and CHOP protein levels after status epilepticus. α-Tubulin is shown as loading control. 
(F) Graph showing absence of chop mRNA expression in chop knock-out mice 6 h after status epilepticus (n = 4). 
(G) Increased levels of the activity-regulated gene c-fos in wt and chop-deficient mice 6 h after status epilepticus. 
No significant differences between wt and chop-deficient mice (p = 0.1). (n = 4 (chop-/- and 6 (wt)).*p < 0.05; **p < 
0.01; Scale bar = 150 μm in (B) and 100 μm in (D). CA (cornu ammonis); DG (dentate gyrus). 
Chop and seizures
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Immunohistochemistry
Mice were perfused with 4% paraformalde-
hyde, brains extracted, post-fixed and 
cryoprotected in 30% sucrose solution, and 30 
µm sagittal sections were cut on a Leica 
cryostat. Next, brain sections were pretreated 
for 1 h with 1% bovine serum albumin, 5% fetal 
bovine serum and 0.2% Triton™ X-100 and then 
incubated with Neuropeptide Y (NPY) (Sigma-
Aldrich, Dublin, Ireland) primary antibody. 
Finally, brain sections were incubated in avidin-
biotin complex using the Elite® VECTASTAIN® 
kit (Vector Laboratories, Peterborough, UK). 
Chromogen reactions were performed with 
diaminobenzidine (Sigma-Aldrich, Dublin, 
Ireland) and 0.003% hydrogen peroxide for 
10 min. Sections were coverslipped with 
Fluorosave and imaged using a Nikon 2000 s 
epifluorescence microscope with a Hamamatsu 
Orca 285 camera (Micron-Optical).
RNA extraction and real-time quantitative  
polymerase chain reaction
RNA extraction was undertaken as previously 
described using TRIzol® (Invitrogen, Marseille, 
France) [24]. Briefly, 1 µg of total RNA was used 
to generate complementary DNA by reverse 
transcription using SuperScript® II reverse 
transcriptase enzyme (Invitrogen, Marseille, 
France). Quantitative real-time PCR was per-
formed using a LightCycler 1.5 (Roche 
Diagnostics, Sussex, UK) in combination with 
QuantiTect® SYBR® Green PCR kit (Qiagen, 
Sussex, UK) as per manufacturer’s protocol, 
and 1.25 µM of primer pair was used. Data 
were analysed by LightCycler 1.5 software, 
data were normalized to expression of β-actin 
and represented as relative quantification val-
ues. Primers were designed using Primer3 soft-
ware (http://frodo.wi.mit.edu) and were verified 
by basic local alignment search tool BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Pri- 
mers sequences: chop: forward 5’-gaataacagc-
cggaacctga-3’, reverse 5’-cgtttcctggggatgaga-
ta-3’; c-fos: forward 5’ggaattaacctggtgctgga, 
reverse 3’cattcagaccacctcgacaa, mbp (against 
all isoforms): forward 5’cacgctggagatatgtgtgg, 
reverse 3’accatgagaagtggccagag and β-actin: 
forward 5’gggtgtgatggtgggaatgg, reverse 3’gg- 
ttggccttagggttcagg.
Microarray analysis
Microarray studies and data were reported pre-
viously [17] and undertaken at an Affymetrix 
authorized service provider (University College 
Dublin, Dublin, Ireland) [17, 24]. Briefly, total 
RNA was extracted from wild-type and chop-/- 
mice 6 h after status epilepticus and was 
hybridized to the Mouse Genome 430 2.0 
Genechip array. Affymetrix GeneChip image 
files were analysed by robust multichip analysis 
using RMAExpress 0.5 (http://rmaexpress.
bmbolstad.com). Data were log transformed, 
and the threshold for significant regulation was 
set at 1.5-fold to retain genes that exhibit a 
biologically meaningful level of regulation, but 
not exclude certain genes that, because of high 
constitutive expression, may show lower 
degrees of change. Gene ontology and function 
were assigned by interrogating the database 
for annotation, visualization and integrated 
discovery (http://david.abcc.ncifcrf.gov/), Cyto- 
scape (http://www.cytoscape.org) and the pub-
lished literature. Putative CHOP DNA binding 
sites were identified using the Algen Promo 
database (http://alggen.lsi.upc.es/cgi-bin/pro- 
mo_v3/promo/promoinit.cgi?dirDB=TF_8.3).
Western blot analysis
Western blotting was performed as previously 
described [17]. Proteins were extracted from 
hippocampus, separated by SDS-PAGE and 
transferred to nitrocellulose membranes and 
then immunoblotted with the following primary 
antibodies: CHOP (Santa Cruz Biotechnology, 
Heidelberg, Germany), KDEL (Millipore, Cork, 
Ireland), Mbp (ABCAM, Cambridge, UK) and 
β-actin and α-tubulin (Sigma-Aldrich, Dublin, 
Ireland). Horseradish peroxidase-conjugated 
antibodies (Cell Signaling Technology, Denver, 
USA) were then applied and used as secondary 
antibodies. Protein bands were visualized using 
SuperSignal® West Pico Chemiluminescent 
Substrate (Pierce). Gel band image densities 
were captured using a Fuji-film LAS-3000 and 
analyzed using Alpha-EaseFC4.0 software.
Data analysis
Data are presented as mean ± standard error 
of the mean (SEM). Data were analysed using 
ANOVA with post hoc Fisher’s protected least 
significant difference test (StatView) and 
Student’s t-test for two-group comparison. 
Significance was accepted at P < 0.05.
Results
Hippocampal CHOP protein levels are in-
creased after status epilepticus and during 
process of epileptogenesis
To identify novel CHOP target genes expressed 
after cellular stress we used our well charac- 
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terized intra-amygdala status 
epilepticus mouse model which 
shows a robust CHOP induction 
[17, 23]. Mice were microinjected 
with pro-convulsive KA into the 
amygdala and experienced first 
seizure bursts shortly afterwards 
(Figure 1A). Mice then went on 
and developed continuous status 
epilepticus. To reduce morbidity 
and mortality mice were injected 
with the anticonvulsant loraze-
pam 40 minutes after KA 
injection. Intra-hippocampal re- 
cording confirmed the recruit-
ment of hippocampal structures 
during status epilepticus (Figure 
1A). As reported previously [25], 
neuronal cell death was most 
prominent in the ipsi-lateral CA3 
subfield (Figure 1B). Hippocampal 
cell death was absent in vehicle-
injected mice (data not shown 
and [25]). 
We monitored a subset of mice to 
confirm they developed spon- 
taneous seizures after a short 
latent period of approximately 2 
to 3 days (Figure 1C and [25]). To 
analyze a possible reorganization 
of the hippocampus, we stained 
sections from mice killed 14 days 
after status epilepticus against 
Neuropeptide Y (NPY), which is a 
marker of synaptic rearrange-
ment (Figure 1D). NPY staining in 
vehicle injected control mice was 
mainly present in hilar neurons 
and occasionally in cells sur-
rounding the stratum pyramidale 
layer. In contrast, NPY staining 
was markedly increased in the 
hippocampus of epileptic wild-
type mice. This was most evident 
along the mossy fiber pathway 
and in the outer molecular layer 
of the dentate gyrus (Figure 1D). 
As published previously, ER- 
stress markers BiP and CHOP 
protein levels increase shortly 
after status epilepticus (Figure 
1E and [17, 23]). Interestingly, 
CHOP protein levels are not only 
up-regulated shortly after status 
Figure 2. Gene expression profiling in chop-deficient mice after status 
epilepticus. (A) ‘Heatmap’ representing microarray analysis of the ipsila- 
teral hippocampus 6 h after status epilepticus of up- and downregulated 
genes in chop-deficient mice when compared to wt mice (n = 1 per group, 
each sample was a pool of 4 hippocampi from different animals). (B) Pie 
chart showing total amount of genes up- (red) and down-regulated (blue) 
in chop-deficient mice when compared to wt mice 6 h after status epile- 
pticus. (C) Graph showing average fold change of up-and down-regulated 
genes in chop-deficient mice when compared to wt mice. (D-H) Gene onto- 
logy analysis of genes up-and down-regulated in chop-deficient mice when 
compared to wt mice 6 h after status epilepticus. The DAVID bioinformatic 
tool was used to categorize the chop-regulated gene list according to GO 
processes (D) Cellular component; (E, F) Biological process and (G, H) Mole- 
cular function.
Chop and seizures
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epilepticus and during chronic epilepsy (Figure 
1E and [17]), but also during the seizure-free 
latent period (Figure 1E).
Gene ontology analysis of po- 
tential CHOP-regulated target genes after sta-
tus epilepticus
In the present model, chop-deficient mice dis-
play increased susceptibility to seizure-induced 
cell death, a shorter latent period and an aggra-
vated epileptic phenotype, experiencing up to 
three times more spontaneous seizures than 
wild-type mice [17]. The increased cell death 
has been linked to higher p53 levels in chop-
deficient mice, possibly due to a decreased 
expression of the E3 ubiquitin ligase MDM2 
which targets p53 for its degradation by the 
proteasome [17]. However, increased p53 le- 
vels have also been linked to decreased sei-
zure frequency in epileptic mice [26] which su- 
ggest that other mechanisms might contribute 
to the increased seizure susceptibility in chop-
deficient mice. To test this idea we looked again 
at the microarray profile of wild-type (wt) and 
mice lacking chop (chop-/-) subjected to status 
epilepticus. Previous analysis revealed a strong 
increase of the genes down-stream of the tran-
scription factor p53 in chop-deficient mice 
when compared to wt vehicle injected mice 
[26]. To extend these data, we performed an in 
depth re-analysis of the microarray data 
focusing on different pathways altered in chop-
/- mice. In contrast to our previous analysis, 
where gene expression profile of chop-/- mice 
and wt mice subjected to status epilepticus 
was compared to vehicle injected seizure- free 
wt mice [26], this time we chose a direct com-
Figure 3. Biological functional pathways down-regulated in chop-deficient mice after status epilepticus. A. Diagram 
showing network of gene sets (nodes) related by mutual overlap (edges, green), where color (grey) indicates the 
class of gene sets. The size of the node corresponds to the number of genes in the GO term and colour of the node 
(blue) relates to the p-value of GO term. B. GO term associated with each gene set.
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parison of chop-/- mice which underwent status 
epilepticus to wt mice which also experienced 
status epilepticus. In addition, minimum fold 
change was lowered from 2 to 1.5. 
As previously reported [17] and expected, chop 
mRNA expression was absent in chop knock-
out mice (Figure 1F) and impact on seizures 
was similar between wt and chop-/- mice, 
although chop-/- showed slightly increased c-fos 
mRNA expression (Figure 1G). Because CHOP 
has the ability to either decrease or increase 
target gene expression [5], we compared fold-
changes of genes which were up- or down- 
regulated in chop-/- mice after status epilepti-
cus when compared to wt seizure mice. Total 
gene numbers (Figure 2B) and fold genes 
(Figure 2A, 2C) were similar between groups, 
suggesting that loss of CHOP has similar effects 
to both, increase and decrease gene expres-
sion after status epilepticus. 
To explore the biological functions of CHOP, we 
used the gene ontology software DAVID and 
analyzed biological processes, molecular 
function and cellular component (Figure 2D-H). 
Similar numbers for up- and down-regulated 
genes were obtained for cellular component, 
although up-regulation was more common for 
genes associated with membrane and intra- 
Figure 4. Biological functional pathways up-regulated in chop-deficient mice after status epilepticus. A. Diagram 
showing network of nodes related by mutual overlap where grey color indicates the class of gene sets. The size of 
the node corresponds to the number of genes in the GO term and colour of the node (red) relates to the p-value of 
GO term. B. GO term associated with each gene set.
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Table 1. Potential CHOP-regulated genes after seizures identified by microarray analysis
Upregulated
Molecular Function Gene Symbol Gene Name Accession no.
Fold 
Change Biological Function
Epilepsy 
Citations
CHOP  
Citations
CHOP 
PBS
Purine Nucleotide  
Binding (38)
Prkcd Protein kinase C, delta NM_011103 2.62965 Negative regulation of MAP kinase activity, apoptosis, 
phosphorylation, negative regulation of actin filament 
polymerisation
6 7 25
Gnai3 Guanine nucleotide binding protein  
(G protein), alpha inhibiting 3
NM_010306 1.94658 GPCR signalling, cell division, vesicle fusion 0 0 17
Rab37 RAB37, member of RAS oncogene family NM_001163753 1.7972 GTP catabolic process, protein transport 0 0 29
Structural Molecular  
Activity (13)
Ctse Cathepsin E NM_007799 2.32074 Processing of antigenic peptides during MHC class  
II-mediated antigen presentation
0 0 16
Mbp Myelin basic protein NM_001025245 1.93847 Membrane organisation, myelination 29 4 29
Cytoskeleton Protein  
Binding (13)
Synpo2 Synaptopodin 2 NM_080451 2.00806 Actin-binding, actin-bundling activity 0 0 27
Gsn Gelsolin NM_146120 1.68303 Regulation of cell adhesion, cell projection,  
cilium morphogenesis
3 2 29
Protein Dimerisation  
Activity (10)
Pm20d1 Peptidase M20 domain containing 1 NM_178079 1.79775 Metabolic process, regulation of neuron  
death, proteolysis
0 0 23
Phosphoprotein  
Phosphotase Activity (6)
Ptpdc1 Protein tyrosine phosphatase domain  
containing 1
NM_207232 1.93937 Protein dephosphorylation, cell projection 0 0 28
Downregulated
Molecular Function Gene Symbol Gene Name Accession no.
Fold 
Change Biological Function
Epilepsy 
Citations
CHOP  
Citations
CHOP 
PBS
Ion Binding (57) Mid1 Midline 1 NM_010797 4.85018 Negative regulation of microtubule  
depolymerisation
0 0 27
Cdh7 Cadherin 7, type 2 NM_172853 2.73727 Cell adhesion 1 0 34
Rnf41 Ring finger protein 41 NM_001164237 1.51254 Negative regulation of cell proliferation,  
protein ubiquitination
1 0 32
Zkscan6 Zinc finger with KRAB and SCAN domains 6 NM_026107 1.98704 Regulation of transcription, transcription 0 0 22
Nucleotide Binding (34) Mcm6 Minichromosome maintenance deficient 6 
(MIS5 homolog, S. Pombe) (S. Cerevisiae)
NM_008567 2.45372 DNA replication 0 0 26
Kif1a Kinesin family member 1A NM_001110315 2.11829 Vesicle-mediated transport, microtubule-based  
movement, ATP catabolic process
1 0 25
Stk25 Serine/threonine kinase 25 (yeast) NM_021537 2.10611 Golgi localisation, apoptosis, establishment/mainte- 
nance of cell polarity,  positive regulation of axonogenesis
0 0 25
Peptide Activity (13) Serpinb2 Serine (or cysteine) peptidase inhibitor,  
clade B, member 2
NM_001174170 1.93399 Negative regulation of apoptosis and peptidase activity 8 3 19
Cytokine Activity (7) Ccl21a Chemokine (C-C motif) ligand 21A (serine) NM_011124 6.26678 Cell chemotaxis, positive regulation of T cell migration 0 0 16
ATPase Activity (7) ATP8a1 Atpase, aminophospholipid transporter  
(APLT), class I, type 8A, member 1
NM_001038999 3.61592 Phospholipid transport, cation transport 0 0 29
Table 1 showing list of up- and down-regulated genes identified by microarray analysis in chop-/- mice when compared to wt mice (both genotypes underwent status epilepticus before). Top 10% of genes with highest fold change for each 
molecular function category are shown. Epilepsy and CHOP citations according to Pubmed. (PBS) - Potential Binding Sites.
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cellular organelles (Figure 2D). Among the most 
enriched biological processes in the up-regula- 
ted genes were processes involved in pho- 
sphorylation, intracellular signalling, protein 
localization and regulation of cell death (Figures 
2E and 4) whereas in the down-regulated genes 
the most prominent processes involved beha- 
viour, DNA metabolism and chemotaxis (Figures 
2F and 3). When we analyzed molecular fun- 
ction, nucleotide binding was highly enriched 
among up- and down-regulated gene sets 
(Figures 2G, 2H, 3 and 4) whereas ion binding 
was the major group among the down- 
regulated genes (Figures 2H and 3). Intere- 
stingly, GO terms relating to ”Action potential/
Ion homeostasis” and “Axon remodelling” were 
one of the most highly represented groups 
identified in enrichment maps of the up-regulat-
ed genes which were created using the bioinfor-
matics program cytoscape [27] (Figure 4).
Table 1 gives a summary of the most up- and 
down-regulated genes of each of the categories 
identified under molecular functions including 
numbers of putative binding sites in the CHOP 
promoter region.
Loss of CHOP alters expression of genes  
associated with the formation of the myelin 
sheath after seizures
A common cellular response following status 
epilepticus is axonal sprouting and rewiring of 
the brain, which may increase the brain’s 
susceptibility to increased seizure frequency 
[28, 29] and mossy fibre sprouting is also 
common in resected human hippocampus [30]. 
To identify CHOP-controlled genes which might 
impact on axon sprouting and rewiring we 
focused on the enriched gene group “Axon 
remodelling” (Figure 4A). Here, we identified 
Figure 5. Increased induction of genes related to myelin sheath in chop-deficient mice after status epilepticus. 
A. Diagram showing main components of the myelin sheath in the CNS and PNS (Cx32, Connexin32; PMP22, 
peripheral myelin protein 22). (red = up-regulated in chop-/- mice after status epilepticus; green = no change in 
mRNA induction in chop-/- mice after status epilepticus). B. Table showing myelin-associated proteins up-regulated 
in chop-/- mice after status epilepticus detected by microarray (PBS = potential CHOP binding site). C. Cartoon 
showing putative binding sites for CHOP in the promoter region of the mbp gene (Mus musculus, myelin basic protein 
(Mbp), transcript variant 1, mRNA, NCBI Reference Sequence: NM_001025251.2). D. Graph showing decreased 
mbp mRNA in hippocampal tissue of wt mice when compared to vehicle injected control mice and chop-/- mice 6 
h after status epilepticus. No significant change in mbp mRNA levels between vehicle wt mice and chop-/- mice 
after status epilepticus (n = 4 (Con wt and chop-/-) and 6 (SE wt). E. Western blot and F. graph showing increased 
hippocampal Mbp protein levels in epileptic chop-/- mice when compared to epileptic wt mice at day 14 post KA 
injection. β-actin was used as loading control (n = 5 (wt) and 4 (chop-/-)).
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several genes which code for key proteins of 
the myelin sheath in the CNS (Figure 5A, 5B). 
The insulating multilamellar myelin sheath 
improves neuronal communication by increas-
ing impulse propagation velocity along axons 
and demyelination has been described as a 
pathological characteristic in animal seizure 
models of status epilepticus and in some forms 
of human epilepsies [31, 32]. Furthermore, 
CHOP has been proposed to be actively involved 
in the demyelination process, however, without 
any specifications of its potential targets [33]. 
We therefore decided to pursue further genes 
involved in myelination and validate Mbp 
(myelin basic protein), one of the major 
components of CNS myelin [34], as a possible 
CHOP target gene (Figure 5A-C). Quantification 
of qPCR data showed that mbp mRNA was 
significantly down-regulated in wt mice after 
status epilepticus compared to seizure-free 
vehicle-injected wt mice and to chop-/- mice 
subjected to status epilepticus (Figure 5D), 
suggesting CHOP acts as a negative regulator 
of mbd transcription. Western blotting against 
Mbp protein in epileptic mice confirmed higher 
Mbp levels in the hippocampus of chop-/- mice 
when compared to wt mice (Figure 5E, 5F).
Discussion
In the present study we identified potential 
novel CHOP-regulated target genes by using 
mRNA microarray analysis of chop-deficient 
mice subjected to status epilepticus. Our study 
confirmed a robust increase in hippocampal 
CHOP protein after seizures and showed, in 
addition, a strong up-regulation of CHOP during 
the seizure free latent period [25]. Bioinformatic 
analysis identified cell death-promoting path-
ways but also cell death-related pathways to be 
altered in chop knockout mice. One of these 
pathways included several key proteins of the 
myelin sheath and further validation confirmed 
a blocked down-regulation of the myelin basic 
protein after seizures in the absence of CHOP. 
These results suggest that CHOP acts in a simi-
lar way to myelin-associated inhibitors sup-
pressing the transcription of myelin-associated 
genes.
One of our first findings was the strong 
up-regulation of CHOP during the latent period 
(24 to 72 h post KA injection), during which 
mice normally show no seizure activity [25]. 
These results are in line with CHOP being 
upregulated by chronic stress of the endopla- 
smatic reticulum which has been shown to be 
up-regulated during epileptogenesis [35]. 
These results also imply CHOP as not simply an 
inducer of apoptosis because major cell death 
does not increase beyond 24 h post KA inje- 
ction in our seizure model [17]. Moreover, CHOP 
protein has been reported to be increased in 
cell death-resistant brain regions after status 
epilepticus [17].
CHOP was initially described as a dominant 
negative factor, blocking the activation of other 
C/EBP proteins or transcription factors by 
forming heterodimers, but it can also bind to 
DNA as a heterodimer and induce transcription 
of target genes [1]. The fact that we found simi-
lar numbers of genes up-and down-regulated, 
with similar fold changes in chop-deficient mice 
after status epilepticus suggests that CHOP 
acts as both an inducer and blocker of 
transcription after seizures. In fact, previous 
results demonstrated that CHOP is able to 
target MDM2 and chop-deficient mice fail to 
induce MDM2 expression after status 
epilepticus in our model, thereby increasing 
p53 levels [17]. Our present results are consis-
tent with CHOP being able to block the 
expression of many other genes, suggesting 
that CHOP has the ability to respond to the 
same stress stimulus by either up- or-down-
regulating the expression of target genes. 
However, we do not know what percentage of 
up- or down-regulated target genes are direct 
targets of CHOP or a mere consequence of 
CHOP altering up-stream signalling such as 
altering the expression of transcription factors 
(e.g. p53 [17]). In depth analysis of gene pools 
showed that more functional pathways are 
altered among the up-regulated genes, which 
might be the consequence of indirect CHOP 
targeting. Interestingly, even though apoptotic 
pathway changes in chop-/- mice have been 
detected, they seem to be not the only major 
contributors to the overall gene changes 
observed. Apoptotic pathways were also mainly 
detected in the up-regulated gene pool, 
implying that CHOP mainly acts as a transcrip-
tion inhibitor of cell death-related genes after 
seizures. Again, we cannot rule out additional 
effects of CHOP altering up-stream pathways 
such as the pro-apoptotic p53 pathway 
previously mentioned [17]. 
The most striking difference between up- and 
down-regulated genes in the chop-/- mice is the 
overrepresentation of genes involved in ion 
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binding in the down-regulated gene pool. 
Interestingly, this list includes genes which 
regulate potassium channels (e.g. Kcnq2 
(potassium voltage-gated channel, subfamily Q, 
member 2) and Kcnj6 (potassium inwardly- 
rectifying channel, subfamily J, member 6)), 
both of which have been implicated in epilepsy 
[36, 37]) and the E3 ubiquitin ligase MID1 [38], 
which belongs to the same protein family as the 
E3 ubiquitin ligase MDM2, previously  identified 
as a CHOP target gene in our model [17]. 
Among the up-regulated genes we identified 
genes involved in numerous processes with the 
most enriched gene sets being related to cell 
proliferation and development, regulation of 
gene expression, cell death and the generation 
of action potentials and axonal remodelling. 
Interestingly, previous mRNA microarray 
analysis of CHOP-overexpressing cells also 
identified genes involved in cell proliferation, 
development and apoptosis as one of the major 
pathways altered [2].
We focused our attention then to genes 
involved in axonal remodelling, as this is one of 
the main pathological changes during 
epileptogenesis [39] and identified here 
several genes involved in myelination. 
Demyelination is a pathological characteristic 
of animal epilepsy models and has been 
described in some types of epilepsy [31, 32]. 
Here, the myelin basic protein Mbp seems to 
play a pivotal role. Myelin sheath damage 
seems to be an early pathological characte- 
ristic of epileptogenesis [31] and epileptic 
seizures have been associated with Mbp 
release from the damaged regions of the myelin 
sheaths [40]. In another study, Mbp expression 
was significantly lower in epileptic rats when 
compared to control rats [41]. Our results now 
extend these data showing a significant 
reduction in mbp mRNA induction after 
seizures. The expression of myelin-associated 
proteins is tightly regulated by transcription 
factors which induce their expression such as 
SP1 [42], Sox10 [43] or OLIG1 [44] and 
negative regulators of their expression (myelin 
associated inhibitors) such as Nogo-A, MAG or 
OMgp [45]. Critically, myelin-associated 
inhibitors have also been implicated in regula- 
ting axonal regeneration, plasticity and 
sprouting [45]. Our results suggest that CHOP 
can act as such a myelin-associated inhibitor, 
blocking the transcription of myelin-associated 
genes such as Mbp. Our results are in line with 
previous findings where chop deletion in a 
Charcot-Marie-Tooth 1B mouse model 
completely rescued motor deficit and reduced 
demyelination in the peripheral nerves [46] and 
with the observed demyelination after spinal 
cord injury following valproate treatment which 
decreased CHOP protein levels [33]. The 
decreased induction of myelin-associated 
proteins rather than a direct consequence of 
CHOP-regulated transcriptional repression 
might be a consequence of oligodentrocyte 
death as a response to CHOP overexpression. 
However, this is unlikely, as chop-deficiency 
has been reported to increase cell death after 
excitotoxicity [17] and CHOP overexpression led 
to increased oligodentrocyte survival [18]. 
An obvious caveat is that seizure-induced cell 
death is increased in chop-/- mice [17], 
therefore gene expression changes may be 
secondary to neurodegeneration. However, this 
is mitigated somewhat by the early sampling 
time used for the microarray analysis (6 h).
We do not know what the consequences are of 
a down-regulation of myelin-associated 
proteins on the epileptic phenotype. Mice 
deficient in mbd display spontaneous seizures 
[47] and mice deficient in mag showed 
increased susceptibility to kainic acid [48]. 
Therefore, it is tempting to speculate that the 
transcriptional repression of myelin-associated 
proteins through CHOP renders mice more 
susceptible to seizures and therefore CHOP 
over-expression has pro-epileptogenic 
potential. However, chop-deficient mice show 
an increased seizure frequency [17] and 
myelin-associated inhibitors have been 
involved in axonal plasticity and sprouting [45], 
processes believed to contribute to the 
epileptic phenotype [28, 29]. Future experi- 
ments will have to examine the exact role of 
CHOP-induced demyelination, possibly by 
reducing genetically, either by cross breeding 
or viral infections, the gene load of mbp in 
chop-deficient mice. 
In conclusion, the present work describes novel 
molecular pathways altered after seizures in 
the absence of chop and identified myelin-
associated proteins as potential novel CHOP 
target genes. This study extends the potential 
role of CHOP beyond control of apoptosis and 
suggests that CHOP could be targeted to 
influence axonal regeneration or reorgani- 
sation.
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